Healthy Extracts Inc. has announced preliminary unaudited results for the second quarter of 2025, with expectations of record sales and strong positive adjusted EBITDA at nearly $100,000. The company's growth has been driven by subscription-based recurring revenue, which saw a more than 107% increase from Amazon "Subscribe & Save" customers and an 88% increase in direct-to-consumer subscription customers. Healthy Extracts anticipates maintaining a robust performance with a projected net revenue growth of 34% for the full year 2025. The company has achieved record-setting revenue for three consecutive quarters, credited to effective growth strategies and expansion across direct-to-consumer and retail channels. Healthy Extracts has recently launched new product formulations, expanding into sleep and gut health categories. These new offerings, combined with strategic cross-promotion and a top three ranking on Amazon, fortify the company's market position. Looking ahead, Healthy Extracts plans to continue its growth trajectory by introducing additional products and categories in the third quarter, including a novel oral delivery system developed in partnership with Gelteq. The company aims to sustain its revenue and profitability growth through strategic reinvestment in product development and channel expansion.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。